United States Constipation Treatment Market Report 2017

October 2017 | 106 pages | ID: UB8261AEAD6PEN
QYResearch

Abstracts

In this report, the United States Constipation Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Constipation Treatment in these regions, from 2012 to 2022 (forecast).

United States Constipation Treatment market competition by top manufacturers/players, with Constipation Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer AG
• Ironwood Pharmaceuticals, Inc.
• Takeda Pharmaceuticals Company Limited
• Sanofi
• AstraZeneca
• Abbott Laboratories
• Sucampo Pharmaceuticals, Inc.
• Synergy Pharmaceuticals, Inc.
• Valeant Pharmaceuticals International, Inc.
• Valeant Pharmaceuticals International, Inc.
• Janssen Pharmaceutical Company
• Daewoong Pharmaceuticals Co. Ltd.
• Prestige Brands Holdings, Inc.
• Shionogi & Co., Ltd.
• Renexxion, LLC.
• Albireo Pharma, Inc.
• Cosmo Pharmaceuticals NV.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Chronic idiopathic constipation (CIC)
• Irritable bowel syndrome with constipation (IBS-C)
• Opioid-induced constipation (OIC)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Constipation Treatment for each application, including

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Contents

United States Constipation Treatment Market Report 2017

1 CONSTIPATION TREATMENT OVERVIEW

1.1 Product Overview and Scope of Constipation Treatment
1.2 Classification of Constipation Treatment by Product Category
  1.2.1 United States Constipation Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Constipation Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Chronic idiopathic constipation (CIC)
  1.2.4 Irritable bowel syndrome with constipation (IBS-C)
  1.2.5 Opioid-induced constipation (OIC)
1.3 United States Constipation Treatment Market by Application/End Users
  1.3.1 United States Constipation Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 United States Constipation Treatment Market by Region
  1.4.1 United States Constipation Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Constipation Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Constipation Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Constipation Treatment Status and Prospect (2012-2022)
  1.4.5 New England Constipation Treatment Status and Prospect (2012-2022)
  1.4.6 The South Constipation Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Constipation Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Constipation Treatment (2012-2022)
  1.5.1 United States Constipation Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Constipation Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES CONSTIPATION TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Constipation Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Constipation Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Constipation Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Constipation Treatment Market Competitive Situation and Trends
  2.4.1 United States Constipation Treatment Market Concentration Rate
  2.4.2 United States Constipation Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Constipation Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CONSTIPATION TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Constipation Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Constipation Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Constipation Treatment Price by Region (2012-2017)

4 UNITED STATES CONSTIPATION TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Constipation Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Constipation Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Constipation Treatment Price by Type (2012-2017)
4.4 United States Constipation Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CONSTIPATION TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Constipation Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Constipation Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CONSTIPATION TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Constipation Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer AG Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Ironwood Pharmaceuticals, Inc.
  6.2.2 Constipation Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ironwood Pharmaceuticals, Inc. Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceuticals Company Limited
  6.3.2 Constipation Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceuticals Company Limited Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Constipation Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca
  6.5.2 Constipation Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Abbott Laboratories
  6.6.2 Constipation Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Laboratories Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sucampo Pharmaceuticals, Inc.
  6.7.2 Constipation Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sucampo Pharmaceuticals, Inc. Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Synergy Pharmaceuticals, Inc.
  6.8.2 Constipation Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Synergy Pharmaceuticals, Inc. Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Valeant Pharmaceuticals International, Inc.
  6.9.2 Constipation Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Valeant Pharmaceuticals International, Inc.
  6.10.2 Constipation Treatment Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Janssen Pharmaceutical Company
6.12 Daewoong Pharmaceuticals Co. Ltd.
6.13 Prestige Brands Holdings, Inc.
6.14 Shionogi & Co., Ltd.
6.15 Renexxion, LLC.
6.16 Albireo Pharma, Inc.
6.17 Cosmo Pharmaceuticals NV.

7 CONSTIPATION TREATMENT MANUFACTURING COST ANALYSIS

7.1 Constipation Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Constipation Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Constipation Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Constipation Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CONSTIPATION TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Constipation Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Constipation Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Constipation Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Constipation Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Constipation Treatment
Figure United States Constipation Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Constipation Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Chronic idiopathic constipation (CIC) Product Picture
Figure Irritable bowel syndrome with constipation (IBS-C) Product Picture
Figure Opioid-induced constipation (OIC) Product Picture
Figure United States Constipation Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Constipation Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacies Examples
Figure United States Constipation Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Constipation Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Constipation Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Constipation Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Constipation Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Constipation Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Constipation Treatment Sales Share by Players/Suppliers
Figure 2017 United States Constipation Treatment Sales Share by Players/Suppliers
Figure United States Constipation Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Constipation Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Constipation Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Constipation Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Constipation Treatment Revenue Share by Players/Suppliers
Table United States Market Constipation Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Constipation Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Constipation Treatment Market Share of Top 3 Players/Suppliers
Figure United States Constipation Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Constipation Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Constipation Treatment Product Category
Table United States Constipation Treatment Sales (K Units) by Region (2012-2017)
Table United States Constipation Treatment Sales Share by Region (2012-2017)
Figure United States Constipation Treatment Sales Share by Region (2012-2017)
Figure United States Constipation Treatment Sales Market Share by Region in 2016
Table United States Constipation Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Constipation Treatment Revenue Share by Region (2012-2017)
Figure United States Constipation Treatment Revenue Market Share by Region (2012-2017)
Figure United States Constipation Treatment Revenue Market Share by Region in 2016
Table United States Constipation Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Constipation Treatment Sales (K Units) by Type (2012-2017)
Table United States Constipation Treatment Sales Share by Type (2012-2017)
Figure United States Constipation Treatment Sales Share by Type (2012-2017)
Figure United States Constipation Treatment Sales Market Share by Type in 2016
Table United States Constipation Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Constipation Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Constipation Treatment by Type (2012-2017)
Figure Revenue Market Share of Constipation Treatment by Type in 2016
Table United States Constipation Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Constipation Treatment Sales Growth Rate by Type (2012-2017)
Table United States Constipation Treatment Sales (K Units) by Application (2012-2017)
Table United States Constipation Treatment Sales Market Share by Application (2012-2017)
Figure United States Constipation Treatment Sales Market Share by Application (2012-2017)
Figure United States Constipation Treatment Sales Market Share by Application in 2016
Table United States Constipation Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Constipation Treatment Sales Growth Rate by Application (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Constipation Treatment Sales Growth Rate (2012-2017)
Figure Bayer AG Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Bayer AG Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Ironwood Pharmaceuticals, Inc. Basic Information List
Table Ironwood Pharmaceuticals, Inc. Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ironwood Pharmaceuticals, Inc. Constipation Treatment Sales Growth Rate (2012-2017)
Figure Ironwood Pharmaceuticals, Inc. Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Ironwood Pharmaceuticals, Inc. Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceuticals Company Limited Basic Information List
Table Takeda Pharmaceuticals Company Limited Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Company Limited Constipation Treatment Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Company Limited Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceuticals Company Limited Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Constipation Treatment Sales Growth Rate (2012-2017)
Figure Sanofi Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Sanofi Constipation Treatment Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Constipation Treatment Sales Growth Rate (2012-2017)
Figure AstraZeneca Constipation Treatment Sales Market Share in United States (2012-2017)
Figure AstraZeneca Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Constipation Treatment Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Sucampo Pharmaceuticals, Inc. Basic Information List
Table Sucampo Pharmaceuticals, Inc. Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sucampo Pharmaceuticals, Inc. Constipation Treatment Sales Growth Rate (2012-2017)
Figure Sucampo Pharmaceuticals, Inc. Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Sucampo Pharmaceuticals, Inc. Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Synergy Pharmaceuticals, Inc. Basic Information List
Table Synergy Pharmaceuticals, Inc. Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synergy Pharmaceuticals, Inc. Constipation Treatment Sales Growth Rate (2012-2017)
Figure Synergy Pharmaceuticals, Inc. Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Synergy Pharmaceuticals, Inc. Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals International, Inc. Basic Information List
Table Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals International, Inc. Basic Information List
Table Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Constipation Treatment Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Constipation Treatment Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceutical Company Basic Information List
Table Daewoong Pharmaceuticals Co. Ltd. Basic Information List
Table Prestige Brands Holdings, Inc. Basic Information List
Table Shionogi & Co., Ltd. Basic Information List
Table Renexxion, LLC. Basic Information List
Table Albireo Pharma, Inc. Basic Information List
Table Cosmo Pharmaceuticals NV. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Constipation Treatment
Figure Manufacturing Process Analysis of Constipation Treatment
Figure Constipation Treatment Industrial Chain Analysis
Table Raw Materials Sources of Constipation Treatment Major Players/Suppliers in 2016
Table Major Buyers of Constipation Treatment
Table Distributors/Traders List
Figure United States Constipation Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Constipation Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Constipation Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Constipation Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Constipation Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Constipation Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Constipation Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Constipation Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Constipation Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Constipation Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Constipation Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Constipation Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Constipation Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources